M1 muscarinic acetylcholine receptor in Alzheimer's disease

Shangtong Jiang, Yanfang Li, Cuilin Zhang, Yingjun Zhao, Guojun D Bu, Huaxi Xu, Yun Wu Zhang

Research output: Contribution to journalArticle

66 Scopus citations


The degeneration of cholinergic neurons and cholinergic hypofunction are pathologies associated with Alzheimer's disease (AD). Muscarinic acetylcholine receptors (mAChRs) mediate acetylcholine-induced neurotransmission and five mAChR subtypes (M1-M5) have been identified. Among them, M1 mAChR is widely expressed in the central nervous system and has been implicated in many physiological and pathological brain functions. In addition, M1 mAChR is postulated to be an important therapeutic target for AD and several other neurodegenerative diseases. In this article, we review recent progress in understanding the functional involvement of M1 mAChR in AD pathology and in developing M1 mAChR agonists for AD treatment.

Original languageEnglish (US)
Pages (from-to)295-307
Number of pages13
JournalNeuroscience Bulletin
Issue number2
StatePublished - 2014
Externally publishedYes



  • agonist
  • Alzheimer's disease
  • amyloid
  • cholinergic hypofunction
  • M1 muscarinic acetylcholine receptor
  • tau

ASJC Scopus subject areas

  • Physiology
  • Neuroscience(all)
  • Medicine(all)

Cite this

Jiang, S., Li, Y., Zhang, C., Zhao, Y., Bu, G. D., Xu, H., & Zhang, Y. W. (2014). M1 muscarinic acetylcholine receptor in Alzheimer's disease. Neuroscience Bulletin, 30(2), 295-307. https://doi.org/10.1007/s12264-013-1406-z